Ken Griffin Augmedix, Inc. Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.75 - $4.18 $29,307 - $163,337	-39,076 Reduced 2.07%	1,850,000 $1.63 Million
Q1 2024 May 15, 2024	BUY	$3.2 - $5.83 $5.82 Million - $10.6 Million	1,817,233 Added 2529.45%	1,889,076 $7.73 Million
Q4 2023 Feb 14, 2024	BUY	$4.34 - $5.93 $226,595 - $309,611	52,211 Added 265.95%	71,843 $420,000
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.3 $191,292 - $259,297	-48,924 Reduced 71.36%	19,632 $101,000
Q2 2023 Aug 14, 2023	BUY	$1.65 - $5.05 $95,724 - $292,975	58,015 Added 550.37%	68,556 $329,000
Q1 2023 May 15, 2023	BUY	$1.36 - $1.83 $14,335 - $19,290	10,541 New	10,541 $18,000
Q3 2022 Nov 14, 2022	BUY	$1.45 - $2.35 $33,480 - $54,261	23,090 New	23,090 $33,000

39.7M

Ticker AUGX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,421,200
Market Cap $87.9M
Description
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.